Many people notice that foods they previously enjoyed, particularly high-sugar and high-fat options, become less appealing
If coverage is denied, patients can appeal or request assistance from their provider
for the discovery and development of GLP-1-based drugs that have revolutionized the treatment of #obesity. laskerfoundation.org/winners/glp-1- #Lasker2024 #LaskerLaureate #NovoNordisk Congratulations to Joel Habener, Lotte Bjerre Knudsen, and Svetlana Mojsov, 2024 #LaskerAward winners
We found that patients prescribed semaglutide had a 44% reduced likelihood of a dementia diagnosis compared to those prescribed a non-GLP-1 diabetes management medication, as seen in Figure 1
Ultimately, a provider familiar with your health history can determine whether GLP-1 therapy is appropriate for your situation and, if so, at what dose